FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1046-1047 March 10, 2005 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Sloan, F. A. PubMed Citation

To the Editor: The National Vaccine Advisory Committee, of which I am a member, agrees with the Institute of Medicine (IOM) vaccine-financing committee¹ that legislative measures and additional funding are needed, but we differ with its recommendations for action, as described by Sloan et al. (Dec. 2 issue).² At the request of the IOM committee, the National Vaccine Advisory Committee convened stakeholder deliberations on vaccine-financing options and concluded that it is not advisable to replace the current system with an insurance mandate and a system of subsidies and vouchers, as the IOM recommends. We are skeptical that such a system . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.